Cargando…
Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations
BACKGROUND: Cervical cancer is frequently detected gynecological cancer all over the world. This study was designed to develop a prognostic signature for an effective prediction of cervical cancer prognosis. METHODS: Differentially expressed genes (DEGs) were identified based on copy number variatio...
Autores principales: | Liu, Wenxin, Jiang, Qiuying, Sun, Chao, Liu, ShiHao, Zhao, Zhikun, Wu, Dongfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859909/ https://www.ncbi.nlm.nih.gov/pubmed/35184747 http://dx.doi.org/10.1186/s12885-022-09291-z |
Ejemplares similares
-
Integrated analysis of chromosome copy number variation and gene expression in cervical carcinoma
por: Yan, Deng, et al.
Publicado: (2017) -
Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients
por: Zhao, Hua-fu, et al.
Publicado: (2021) -
Copy number variation signature to predict human ancestry
por: Pronold, Melissa, et al.
Publicado: (2012) -
Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data
por: Zhong, Qihang, et al.
Publicado: (2021) -
Case report: Fetal cervical immature teratoma and copy number variations
por: Li, Dianjie, et al.
Publicado: (2022)